Brand profile · Biotechnology Research

ProGenis Pharmaceuticals

ProGenis Pharmaceuticals is a Biotechnology Research brand in Bentley, Western Australia. It is privately held, and its site is progenispharma.com. It holds one address on record, all in Australia. Headcount on record is 5. Its work is tagged drug Development and RNA Therapeutics. Its latest round on record is Grant, US$239.2K. It is listed alongside seven similar brands, mostly in Biotechnology Research.

LinkedIn

Profile live Privately Held Founded 2021 1 office country US$ 239.2K Grant
Counted staff
5
self-reported band not used
Founded
2021
5 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
1
Grant · Jul 2025 · US$ 239.2K
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Description

ProGenis Pharmaceuticals is focused on developing next generation RNA therapeutics that are more efficient, safer and accessible to treat inherited rare and acquired diseases. ProGenis is headquartered in Perth, Australia, and led by world-renowned experts with significant experience in RNA therapeutics including antisense oligonucleotide chemistries and manufacturing.

Specialties

All 1 specialty
  • Drug Development and RNA Therapeutics

Locations

Australiaprimary

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary AU. Codes: AU.1 countryprimary AUAU
Show as table
Countries1
Primary countryAU

All codes: AU

Addresses

  • AU3 Brodie-Hall Dr; Suite 7 & 10; Bentley, Western Australia 6102Primary

Grid intelligence Members

Funding

Last round · 20 July 2025US$ 239.2KGrant · investor: MTPConnect
Rounds1
Round typeGrant · non-equity funding
Amount (USD)239,200
Stage rank1
Investors named1
Since last round6 mo

Funding

1 funding roundFunding timeline. Latest round 20 Jul 2025: Grant, US$ 239.2K.20212026GrantUS$ 239.2K1 round
Show as table
Rounds1
Axis2021 to 2026
Grant · 20 Jul 2025US$ 239.2K

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Notify me about spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend
Notify me about signals

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
Notify me about financials

People & contacts

3 employee profiles on record · names withheld.

Names are withheld until a consented source exists.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

How many people work at ProGenis Pharmaceuticals?

5 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.

Where does ProGenis Pharmaceuticals have offices?

One address on record, Australia only. Primary: 3 Brodie-Hall Dr, Suite 7 & 10, Bentley, Western Australia 6102.

Has ProGenis Pharmaceuticals raised funding?

One round. Latest 20 July 2025: grant, US$239,200, investor MTPConnect.

What does ProGenis Pharmaceuticals list as its specialties?

One tag on the brand's own list, among them Drug Development and RNA Therapeutics.

Which companies are listed alongside ProGenis Pharmaceuticals?

25 profiles list ProGenis Pharmaceuticals as a peer — 95th percentile in Biotechnology Research. It lists ten peers of its own. Anaxis Pharma and Greenroom Robotics list it back.